GLPBio

Licoricidin

Catalog No.: GC36456Purity:>98%
Licoricidin is an isoflavonoid compound isolated from Glycyrrhiza uralensis Fisch, possessing various biological activities such as anticancer, antibacterial, and anti-inflammatory effects.

Products are for research use only. Not for human use. We do not sell to patients.


Licoricidin
Cas No.: 30508-27-1
1mgIn Stock
$238.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

Licoricidin is an isoflavonoid compound isolated from Glycyrrhiza uralensis Fisch, possessing various biological activities such as anticancer, antibacterial, and anti-inflammatory effects. Licoricidin exerts its anticancer effects by inducing cell cycle arrest, apoptosis, and autophagy, as well as inhibiting tumor angiogenesis and lymphangiogenesis. Licoricidin can be used in research on cancers such as colorectal cancer, gastric cancer, and prostate cancer, as well as in studies related to antibacterial and anti-photoaging activities[1-4].

In vitro, 4T1 murine mammary carcinoma cells were treated with Licoricidin (0–5μg/ml) for 18 hours. Licoricidin significantly inhibited cell migration, MMP-9 secretion, and VCAM expression[5]. Human cervical cancer HeLa, C-33A, and SiHa cells were treated with Licoricidin (20μM) for 24 hours. Licoricidin increased the proportion of apoptotic cells in C-33A and SiHa cells; combined treatment with paclitaxel (10μM) further inhibited the growth of C-33A and HeLa cells, induced apoptosis, and triggered endoplasmic reticulum stress[6].

In vivo, Licoricidin (1mg/mouse; administered orally 5 days per week) was given to atopic dermatitis mouse models induced by dinitrochlorobenzene and/or house dust mite extract for 4 consecutive weeks. Licoricidin significantly alleviated atopic dermatitis symptoms, including reduced ear thickness, serum IgE levels, dermal and epidermal thickness, immune cell infiltration, and decreased mRNA levels of pro-inflammatory cytokines[7]. Licoricidin (10mg/kg and 20mg/kg; administered intraperitoneally every 2 days) was injected into BALB/c-Nu nude mice bearing MGC-803 gastric cancer cell xenograft tumors for 18 days. Licoricidin significantly inhibited tumor growth[8].

References:
[1] Ji S, Tang S, Li K, et al. Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy. Toxicol Appl Pharmacol. 2017 Jul 1;326:25-33.
[2] Wang Y, Wang S, Liu J, et al. Licoricidin enhances gemcitabine-induced cytotoxicity in osteosarcoma cells by suppressing the Akt and NF-κB signal pathways. Chem Biol Interact. 2018 Jun 25;290:44-51.
[3] Kim KJ, Xuan SH, Park SN. Licoricidin, an isoflavonoid isolated from Glycyrrhiza uralensis Fisher, prevents UVA-induced photoaging of human dermal fibroblasts. Int J Cosmet Sci. 2017 Apr;39(2):133-140.
[4] Liu C, He D, Zhao Q. Licoricidin improves neurological dysfunction after traumatic brain injury in mice via regulating FoxO3/Wnt/β-catenin pathway. J Nat Med. 2020 Sep;74(4):767-776.
[5] Park SY, Kwon SJ, Lim SS, et al. Licoricidin, an Active Compound in the Hexane/Ethanol Extract of Glycyrrhiza uralensis, Inhibits Lung Metastasis of 4T1 Murine Mammary Carcinoma Cells. Int J Mol Sci. 2016 Jun 14;17(6):934.
[6] Tai CT, Chen YC, Hsieh YH, et al. Licoricidin Enhances Paclitaxel-induced Apoptosis Through Endoplasmic Reticulum Stress in Human Cervical Cancer Cells. In Vivo. 2025 Nov-Dec;39(6):3195-3204.
[7] Lee HS, Kim J, Choi HG, et al. Licoricidin Abrogates T-Cell Activation by Modulating PTPN1 Activity and Attenuates Atopic Dermatitis In Vivo. J Invest Dermatol. 2021 Oct;141(10):2490-2498.e6.
[8] Ma H, Wu F, Bai Y, et al. Licoricidin combats gastric cancer by targeting the ICMT/Ras pathway in vitro and in vivo. Front Pharmacol. 2022 Oct 13;13:972825.

Protocol

Cell experiment [1]:

Cell lines

4T1 murine mammary carcinoma cells

Preparation Method

4T1 cells were cultured in DMEM containing 10% FBS, penicillin, and streptomycin. Cells were treated with Licoricidin.

Reaction Conditions

0-5μg/mL; 24h

Applications

Licoricidin inhibited the migration of 4T1 cells. Licoricidin treatment reduced the levels of MMP-9 and VCAM-1 in 4T1 cells.

Animal experiment [2]:

Animal models

BALB/c mice (female, 8 weeks old)

Preparation Method

Mice were induced with atopic dermatitis (AD) by applying dinitrochlorobenzene (DNCB) and/or house dust mite extract to the ears, followed by oral administration of Licoricidin for 4 weeks.

Dosage form

1mg/mice; oral administration; five days a week for 4 weeks

Applications

Licoricidin significantly attenuated AD symptoms, including reduced ear thickness, decreased serum IgE levels, thinner dermal and epidermal tissues, diminished infiltration of immune cells (e.g., mast cells), and downregulated mRNA levels of proinflammatory cytokines (IL-4, IL-5, IL-6, IL-13) in ear lesions.

References:
[1] Park SY, Kwon SJ, Lim SS, et al. Licoricidin, an Active Compound in the Hexane/Ethanol Extract of Glycyrrhiza uralensis, Inhibits Lung Metastasis of 4T1 Murine Mammary Carcinoma Cells. Int J Mol Sci. 2016 Jun 14;17(6):934.
[2] Lee HS, Kim J, Choi HG, et al. Licoricidin Abrogates T-Cell Activation by Modulating PTPN1 Activity and Attenuates Atopic Dermatitis In Vivo. J Invest Dermatol. 2021 Oct;141(10):2490-2498.e6.

Chemical Properties

CAS No.
30508-27-1
SMILES
COC1=C2C(OC[C@@H](C3=C(C(C/C=C(C)/C)=C(O)C=C3)O)C2)=CC(O)=C1C/C=C(C)/C
Molecular Formula
C26H32O5
Molecular Weight
424.53
Solubility
Soluble in DMSO
Storage
Store at -20°C
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for Licoricidin

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%